Company or ticker...

Trevi Therapeutics

Trevi develops treatments for chronic cough and serious itching conditions.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

TRVI

2.6B

0.0

n/a

44.28%

Key Facts

M. Cap

PS

PE

YTD

2.6B

0.0

n/a

44.28%

10MA

20MA

50MA

200MA

$TRVI